Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003251 | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 46 | University of Illinois at ChicagoOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003257 | Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer | unknown | Phase 2 | 39 | Aventis PharmaceuticalsINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004226 | Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy | unknown | Phase 1 / Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00623558 | Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) | completed | Phase 2 | 92 | Seoul National University HospitalOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01983176 | Retrospective Clinical Outcome of Parotid Tumor Surgery | completed | — | 767 | National Taiwan University HospitalOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00389441 | Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | completed | Phase 2 | 52 | PfizerINDUSTRY | 9 | Nov 25, 2013 | clinicaltrials |
| NCT01987934 | Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma(OSCC) | unknown | — | 60 | Academy of Interdisciplinary Dental Education and ResearchOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00008398 | Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | completed | Phase 3 | 145 | Dana-Farber Cancer InstituteOTHER | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00095641 | S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 8, 2013 | clinicaltrials |
| NCT01172769 | Efficacy Study of Temsirolimus to Treat Head and Neck Cancer(TEMHEAD) | completed | Phase 2 | 42 | Hannover Medical SchoolOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00557206 | Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 35 | Minneapolis Veterans Affairs Medical CenterFED | 1 | Nov 5, 2013 | clinicaltrials |
| NCT01203618 | Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas | withdrawn | Phase 2 | 0 | MorphotekINDUSTRY | 1 | Nov 4, 2013 | clinicaltrials |
| NCT01184482 | Lapatinib and Cetuximab in Patients With Solid Tumors(TYKERB-ITUX 1) | completed | Phase 1 | 22 | Georgetown UniversityOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT01596868 | GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China | completed | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00620139 | Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | completed | — | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2013 | clinicaltrials |
| NCT00243347 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 2 | Oct 17, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00121628 | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 184 | AmgenINDUSTRY | 0 | Oct 9, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT01954134 | P53 in Differentiated Thyroid Cancer | completed | — | 199 | Cumhuriyet UniversityOTHER | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00049166 | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00847509 | A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation(FLT101) | completed | N/A | 49 | Siemens Molecular ImagingINDUSTRY | 1 | Sep 27, 2013 | clinicaltrials |
| NCT01368133 | The Observational Study of Growth Hormone-secreting Pituitary Tumors | unknown | — | 60 | Huashan HospitalOTHER | 1 | Sep 26, 2013 | clinicaltrials |
| NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | unknown | Phase 3 | 240 | European Institute of OncologyOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | unknown | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00103155 | Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer | unknown | Phase 1 | — | University of California, San FranciscoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00574860 | EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer | terminated | Phase 3 | 240 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01100619 | A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors | completed | Phase 1 | 40 | ExelixisINDUSTRY | 1 | Sep 19, 2013 | clinicaltrials |
| NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 6 | Sep 18, 2013 | clinicaltrials |
| NCT01927354 | Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family. | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Sep 16, 2013 | clinicaltrials |
| NCT00002951 | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | completed | Phase 2 | 53 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00015964 | ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck | completed | Phase 2 | 51 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00002702 | Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx | unknown | Phase 3 | 260 | European Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00720070 | PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer | unknown | Phase 3 | 560 | Warwick Medical SchoolOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01254591 | Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer | unknown | N/A | 500 | University College London (UCL) Cancer InstituteOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00577057 | Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer | unknown | N/A | 798 | Hospital Authority, Hong KongOTHER_GOV | 1 | Aug 22, 2013 | clinicaltrials |
| NCT01271439 | Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma(REPLACE) | completed | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT01118065 | Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer | unknown | Phase 2 | 42 | Leiden University Medical CenterOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01150318 | Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients(SAPIRA) | completed | N/A | 48 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01210872 | Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy | unknown | — | 200 | Centre Georges Francois LeclercOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 3 | — | Cancer Research UKOTHER | 2 | Aug 2, 2013 | clinicaltrials |
| NCT01854203 | Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC(NPC) | unknown | Phase 2 / Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00002507 | Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer | completed | Phase 3 | — | Yale UniversityOTHER | 1 | Jul 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 4, 2013source: clinicaltrials